Tata-backed MedTherapy claims a CAR-T breakthrough, marking what could be a major shift in cancer treatment manufacturing. The company says it can now produce CAR-T therapy within just 24 hours, compared to the several weeks the process usual...
The article explores GLP-1 pathways, berberine, and Metaberine in metabolic health, highlighting multi-pathway, science-backed solutions for better glycemic control and long-term metabolic balance.
.jpeg "India Pharma Moves on ESG but Faces Waste, Energy Hurdles")
ICRA report shows India pharma improving ESG metrics with higher renewable energy use, but facing challenges in energy intensity, hazardous waste, and governance gaps amid global compliance pressure.
P&G Health stock surges 18% after strong Q4 results with 56% profit growth and margin expansion, driven by brand strength, supply chain efficiency, and steady demand outlook.
Tieten Medicity Hospital has successfully performed one of Thane’s first robotic telesurgeries for gall bladder removal (robotic cholecystectomy) using the indigenously developed Mizzo Endo 4000 robotic surgical system.
.jpeg "Bengaluru Ebola Scare Ends Negative, Triggers Health Alert")
Bengaluru Ebola scare ends negative, but triggers health alert as authorities ramp up airport screening, surveillance, and isolation protocols amid global outbreak concerns.
Tata Elxsi has launched ViTel, an AI-driven material intelligence solution for medical device manufacturers, co-developed with Viridium AI. The new platform, formally introduced today at DeviceTalks Boston 2026, aims to help MedTech companie...
Sun Pharma reported a strong financial performance for the fourth quarter of FY26, with Sun Pharma Q4 revenue rising 13.6 per cent to Rs. 14,560 crore and Sun Pharma net profit jumping 26.2 per cent to Rs. 2,714 crore, reflecting healthy growt...
India’s heatwave crisis is turning into a public health emergency, with rising heatstroke deaths, underreported mortality, and growing strain on healthcare systems.
New clinical review validates capsaicin 0.075% for diabetic neuropathy pain relief, offering targeted, localized therapy with improved patient comfort and safety.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")